On April 2, 2018, the Centers for Medicare & Medicaid Services (CMS) issued a final rule to update Medicare Advantage (MA) and the Part D prescription drug benefit program. Included in the final rule, among additional changes, are:
Read a CMS fact sheet that provides details on the major provisions of the final rule.
Posted 4/3/2018
Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
